Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Capital increase in TORM due to exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc (“TORM”) increases its share capital by 17,512 A-shares (corresponding to a nominal value of USD 175.12) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. 10,423 of the new shares have been subscribed for in cash at DKK 43.4 per A-share, the remaining 7,089 of the new shares have been subscribed for in cash at DKK 53.5 per A-share. All with a nominal value of USD 0.01 each.   The new shares are ordinary shares without any special

IAR Systems brings low-code state machine design solution to Linux

Latest version of the state machine design solution IAR Visual State adds cross-platform support for both Windows and Linux, and enables automated generation of C, C++, C# or Java codeUppsala, Sweden—April 8, 2022—IAR Systems®, the world leader of software and services for embedded development, today announced the latest version of the graphical modeling and code generation solution IAR Visual State. The new version introduces cross-platform host support that allows IAR Visual State to run on either Linux or Windows, enabling flexible and efficient development workflows based on state

Eevia Health appoints new distributor

Eevia Health Plc, (”Eevia” or ”The Company”) has appointed Select Ingredients, San Diego, California, USA, as new distributor in the territory of the USA.Eevia Health has appointed Select Ingredients Inc as distributor in the USA. Select Ingredients will focus on organic ingredients for food and supplements applications. The parties will also undertake a joint cooperation on the development and marketing of a new innovative polyphenol extract, which will be sold as a branded ingredient to selected customers. “Select Ingredients is a results-oriented distributor with a strong track record

BioStock: Sprint Biosciences CSO comments on further VADA validation

After last year’s out-licensing of Vps34, the focus is now on the next program in Sprint Bioscience’s portfolio. The VADA program has come the furthest and new research findings provide further validation to the target protein VRK1. In addition to a better understanding of the role the protein plays in cancer, the results also point to a broadened commercial potential for VADA. BioStock contacted Sprint Bioscience’s Head of Research Martin Andersson to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2022/04/sprint-biosciences-cso-comments-on-further-vada-

Toivo Group Plc to carry out a unique 39-apartment and approximately EUR 7.6 million housing project Tuusulan Olympiakasarmi

Press release, 8 April 2022 at 10:00 a.m. Toivo Group Plc (“the Company” or “Toivo”) has acquired a property in Hyrylä, Tuusula, and will start converting the former barracks into apartments during summer 2022. In the project, Toivo will build loft-style rental apartments, due for completion in spring 2023. The apartments will be heated with district heating. Tens of thousands of conscripts have completed their national service at the old garrison area in Hyrylä, Tuusula. In Toivo’s project, one of the barracks buildings will be converted into unique rental apartments. The barracks

Redwood Pharma to attend ARVO (Denver), the most important global conference in ophthalmology

The Association of Researchers in Vision and Ophthalmology will hold their annual meeting in Denver, Colorado (USA) between May 1-4, 2022. ARVO is the world’s leading conference in ophthalmology where researchers from academia and industry can meet to share the latest developments in science and therapeutic development.   Redwood Pharma looks to share developments regarding its RP501 and RP101 therapies for treatment of dry eye disease with potential clinical and commercial partners.   To schedule a meeting please contact:   Martin Vidaeus, CEO Martin.vidaeus@

BillerudKorsnäs’ Annual and Sustainability Report 2021

BillerudKorsnäs publishes its Annual and Sustainability report for 2021. BillerudKorsnäs’ Annual and Sustainability report for 2021 is from today available on the company’s website, www.billerudkorsnas.com/investors/financial-reports, and is attached to this press release. For more information, please contact:Lena Schattauer, Director Investor Relations, +46 8 553 335 10Andreas Drugge, Sustainability Manager, +46 8 553 336 43This information is information that BillerudKorsnäs AB is obliged to make public pursuant to the Securities Market Act. The information was submitted for

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January – March 2022. The presentation will be held in English.Time: Friday 22 April, 2022 at 10.00 a.m. CET.Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 506 921 69International dial in number: +44 (0) 2030 095709Conference name: Vitrolife, conference ID: 6938009Event Passcode: 6938009 Vitrolife participants:Thomas Axelsson, CEOPatrik Tolf, CFOThe press release for Vitrolife’s interim report will be

DOF Subsea awarded multiple contracts for the Ross Candies

DOF Subsea USA is pleased to announce the award of multiple contracts for the Ross Candies. The vessel will be utilised well into Q3 2022, undertaking jumper installations, span remediation, pre-commissioning, decommissioning, pipelay support and IMR activities at multiple field locations in the Gulf of Mexico. For further information, please contact: Mons S. Aase, CEO Tel: +47 91 66 10 12 Hilde Drønen, CFO Tel.: +47 91 66 10 09

Invitation to Kesko’s Q1 interim report briefing on 29 April 2022

A stock exchange release concerning Kesko's financial statements for January-March 2022 will be published on Friday, 29 April 2022, at around 8.00 am (EET/EEST).A teleconference in English will be held at 9.00 am (EET/EEST). It will include a presentation by the President and CEO Mikko Helander, after which the whole Group Management Board will be available for questions. A link to the teleconference is available at www.kesko.fi/report-centre.  Registration is required for the teleconference. A recording of the event

2020 Bulkers Ltd. (2020) – Grant of share options

Hamilton, Bermuda, April 8, 2022 In January 2019, the Board of Directors established a long-term incentive plan and approved a grant of 740,000 share options to employees and directors (the “LTI Plan”). The Board has resolved to grant 60,000 share options to employees including one person discharging managerial responsibilities (“PDMR”) as defined by the Market Abuse Regulation pursuant to the Company's LTI Plan. Each share option gives the holder the right to purchase one share in the Company at an exercise price of US$18 per share. The share options will vest equally over a three

Notice to attend the annual general meeting of SyntheticMR AB (publ)

The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general meeting on Tuesday 10 May 2022, at 18:00 CET at the company's premises on Storgatan 11 in Linköping.Right to attend the general meeting Shareholders who wish to attend the general meeting must: · be registered as a shareholder in share register maintained by Euroclear Sweden AB on the record date, Monday 2 May 2022, and · no later than Wednesday 4 May 2022 at 16:00 CET notify the company of its and any assistants' (no more than two) intention to attend the

Getinge announces its Q1 Report 2022 on April 26 at 08:00 CEST followed by a conference call at 10:00 CEST

Getinge will issue its Q1 Report 2022 on April 26, 2022, at 08:00 CEST, followed by a conference call at 10:00 CEST, hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO.Fund managers, analysts and media are invited to participate in the conference call. Please see dial in details below to join the conference: SE: +46 8 505 583 66UK: +44 333 300 92 71US: +1 631 913 14 22 During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/getinge-q1-2022 Alternatively, use the

GET Group appoints Mangold Fondkommission AB as Mentor in connection with the relisting process on NGM Nordic SME

GET Group AB (“GET Group” or “the Company”) hereby announces that the Company has appointedMangold Fondkommission AB (“Mangold”) as Mentor to the Company at Nordic Growth Markets(NGM), Nordic SME.Mangold will assist the Company in the relisting process requested by NGM Nordic SME as a result ofthe reverse takeovers that have been completed by the Company.During the current relisting process, the Company's shares will continue to be traded under observationon NGM Nordic SME, which is a standard procedure for a reverse takeover which entails a significantchange in company

Invitation to Saab’s Interim Report Q1 2022 Presentation

Saab’s CEO and President Micael Johansson and CFO and deputy CEO Christian Luiga will present the Saab interim report for January-March 2022.Date:            Friday, 22 April at 10:00 (CET). The report is published at 07.30 a.m. (CET) the same day at http://www.saab.com.  You are welcome to watch the live webcast or dial in to the conference call. It is possible to post questions over the conference call and the web.  Live webcast: https://www.saab.com/investors/webcast/q1-2022 Conference call: Please, dial in using one of the numbers below. Sweden:

Notice of the Annual General Meeting in Nexam Chemical Holding AB (publ)

The shareholders of Nexam Chemical Holding AB (publ), 556919-9432 (“Nexam Chemical”), are hereby convened to the Annual General Meeting, to be held at 3.00 p.m. on Wednesday, May 11 2022 at Elite Hotel Ideon, Scheelevägen 27, in Lund.Entitlement to participate and notification Shareholders wishing to attend the annual general meeting must · be listed in the share register kept by Euroclear Sweden AB on Tuesday, May 3 2022, and · not later than Thursday, May 5 2022, inform Nexam Chemical in writing of their attendance and number of assistances, if any, to Nexam Chemical Holding AB

Storskogen's subsidiary Vikingsun acquires Dafra

Storskogen's subsidiary Vikingsun AB (“Vikingsun”) has aqcuired the shares of Dafra Försäljnings Aktiebolag (“Dafra”) from its founders. Dafra is a distributor of approximately 20 brands of kitchen supplies. The company had a turnover of SEK 31m and an EBITA of SEK 4.6m during the last financial year ending in August 2021.Dafra’s history reaches back to 1995 when the company mainly sold frying pans at trade fairs around Sweden. Since then the offering has increased and includes around 700 producs from more than 20 well-known brands. Dafra’s offering is constantly beigin developed and

Notice of Annual General Meeting in Prevas AB (publ)

The shareholders of Prevas AB (publ), corporate registration number 556252-1384, are hereby given notice of the Annual General Meeting to be held on Wednesday May 18th 2022, at 6 p.m. in the Company’s premises at Glödgargränd 14, Västerås (Sweden).RIGHT TO PARTICIPATE Shareholders wishing to attend the Annual General Meeting must: · partly be registered as shareholders in the share register held by Euroclear Sweden AB (”Euroclear”) on Tuesday May 10th 2022, · partly notify the company of their participation by May 12th 2022 at the latest at the address: Prevas AB (publ), Box 4,

Wicket Gaming releases gameplay trailer for Cricket Manager Pro 2022

April 8, 2022, 08:30 Wicket Gaming AB ("Wicket Gaming" or "the Company") releases the gameplay campaign trailer for Cricket Manager Pro 2022.The trailer is the first video production to show the game's ambassador AB de Villiers presence. It will be a part of the broader launch campaign of Cricket Manager Pro 2022, which is now taking place, and which has previously been communicated. Link to gameplay trailer: https://youtu.be/Oa0f7q-d04w   For further information, please contact: Eric de Basso, CEO, Wicket Gaming ABE-mail: eric@wicketgaming.com  Phone: +46 70 780 52 00

Carbiotix first US patent for CarbiAXOS has been allowed for issuance

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the first US patent for the production of CarbiAXOS has been allowed for issuance by the US Patent Office. This is an important milestone as the Company prepares for the launch of a CarbiAXOS nutraceutical ingredient in the US during 2022 and in 2023 begins to plan for US production activities.Carbiotix received confirmation from the USPTO, US patent authority, that the Company’s US Patent Application no.15759228, titled: Low Molecular Weight Arabinoxylans with Branched Oligosaccharides, has been allowed for issuance. This is

Atlas Copco awards recognize innovation, marketing, and operational excellence with focus on sustainability

Nacka, Sweden, April 8, 2022: This year, Atlas Copco’s three most prestigious award recognize the development of a strategic dealer partnership program, a team effort to develop an innovative vacuum measuring device, and the achievements in customized solutions on demand.“We are proud to present the winners of this year’s Giulio Mazzalupi, Peter Wallenberg and John Munck awards”, said Mats Rahmström, President & CEO of the Atlas Copco Group. “They have all shown examples of excellent teamwork and how to drive development forward. The winners have brought increased value to our customers and

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for March 2022

Hamilton, Bermuda, April 8, 2022   Commercial update:   In March 2022, the Company achieved average time charter equivalent earnings of approximately US$27,300 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$25,200 per day, gross, including average daily scrubber benefits of approximately US$2,200 per day. The Company’s two vessels trading on fixed time charter earned approximately US$33,800 per day, gross, including average daily scrubber benefits of approximately US$2,100 per day.   The Baltic 5TC Capesize Index

There are no items matching the current filter
There are no more items matching the current filter
Back to top